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Capsular serotypes of 225 Klebsiella pneumoniae 
isolates in Taiwan were identiﬁ  ed by using PCR. Patients 
infected with K1 serotypes (41 isolates) had increased 
community-onset bacteremia, more nonfatal diseases 
and liver abscesses, lower Pittsburgh bacteremia scores 
and mortality rates, and fewer urinary tract infections than 
patients infected with non–K1/K2 serotypes (147 isolates).
K
lebsiella pneumoniae bacteria cause a variety of 
infections (1,2). Geographic differences in this 
organism have been recognized, and a high prevalence of 
liver abscesses has been observed for >20 years in persons 
in Taiwan infected with K. pneumoniae (3,4). K1 and K2 
are the major capsular serotypes that cause liver abscesses 
and have increased virulence (4–7). In contrast, only 
limited information is available about serotypes causing K. 
pneumoniae bacteremia (3,5).
Yu et al. grouped K1 and K2 serotypes and compared 
clinical characteristics for patients with K. pneumoniae 
bacteremia with those for patients infected with non–K1/
K2 serotypes (3). Recent evidence suggests that K1 is a 
major cause of primary liver abscesses and has greater 
potential for causing metastasis, and that K2 is a major 
cause of secondary liver abscesses (6,8). We examined the 
distribution and clinical characteristics of serotypes that 
cause  K. pneumoniae bacteremia from 225 patients (9) 
and performed PCR-based genotyping to identify capsular 
serotypes (10).
The Study
The study was conducted at Far-Eastern Memorial 
Hospital in Taipei, Taiwan. Patients with K. pneumoniae 
bacteremia were identiﬁ   ed during January 1–December 
31, 2007. Identiﬁ  cation of K. pneumoniae was based on 
colony morphologic features and biochemical reactions 
(11). Data on time until positive blood culture results were 
obtained from the automated blood culture system at the 
hospital. Data for each patient were included only once (at 
the time of the ﬁ  rst detection of bacteremia). Patients <18 
years of age and those not admitted to our hospital were 
excluded. Inactive malignancy was not included as an 
underlying illness. In-hospital and 14-day mortality rates 
were assessed. For 225 available bacterial isolates, cps 
genotyping was performed (10).
A total of 231 patients with K. pneumoniae bacteremia 
were observed at the hospital during the study; 225 isolates 
from 225 patients were used. A total of 133 (59%) of these 
patients had community-onset bacteremia (bacteremia 
identiﬁ   ed in an emergency department). The in-hospital 
mortality rate was 32.4%. Among 225 isolates, 41 (18.2%) 
were identiﬁ  ed as K1 serotype, 37 (16.4%) as K2, 15 (6.7%) 
as K57, and 8 (3.6%) as K54. The K1 serotype was found 
predominantly in community-onset infections (36 [87.8%] 
of 41 patients compared with 75 [51.0%] of 147 patients 
infected with non–K1/K2 serotypes; odds ratio [OR] 6.91, 
95% conﬁ  dence interval [CI] 2.57–18.60) (online Appendix 
Table 1, www.cdc.gov/EID/content/17/6/1113-appT1.htm).
Underlying illness was classiﬁ  ed as nonfatal in 75.6% 
of patients with K1 bacteremia (53.7% of patients with non–
K1/K2 bacteremia; OR 2.67, 95% CI 1.22–5.84). A lower 
percentage of patients with K1 bacteremia had surgery in 
the previous 3 months (9.8% vs. 30.6%; OR 0.25, 95% CI 
0.09–0.73). Patients with K1 bacteremia had lower mean 
± SD Pittsburgh bacteremia scores than those with non–
K1/K2 bacteremia (2.7 ± 3.1 vs. 4.4 ± 4.7; OR 0.90, 95% 
CI 0.81–0.99), but the time until a positive blood culture 
was obtained was not different. K1 serotype was more 
common in patients with liver abscesses (46.3% vs. 4.1%; 
OR 20.3, 95% CI 7.31–56.40) and less common in patients 
with urinary tract infections (UTIs) (4.9% vs. 20.4%; OR 
0.20, 95% CI 0.05–0.88). The in-hospital mortality rate for 
patients with K1 bacteremia was lower that that for patients 
with non–K1/K2 bacteremia (14.6% vs. 34.7%; OR 0.32, 
95% CI 0.13–0.82).
No differences were found in clinical characteristics 
for patients with K2 bacteremia and those with non–K1/K2 
bacteremia except for a higher frequency of liver abscesses 
in patients with K2 bacteremia (13.5% vs. 4.1%; OR 3.67, 
95% CI 1.06–12.8). For patients infected with K54 and 
K57 serotypes, 1 K57 serotype caused liver abscesses; 
no abscesses were found in patients infected with a K54 
serotype. The in-hospital mortality rate was 50% (4/8) for 
patients with K54 bacteremia and 53.3% (8/15) for patients 
with K57 bacteremia.
Patients infected with a K1 serotype had lower mean 
± SD Pittsburgh bacteremia scores (2.7 ± 3.1 vs. 5.0 ± 5.3; 
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and in-hospital mortality rates (9.8% vs. 27.0%; OR 0.29, 
95% CI 0.08–1.03, p = 0.06; and 14.6% vs. 43.2%; OR 
0.23, 95% CI 0.08–0.67, p = 0.007) than patients infected 
with K2 serotypes. A higher percentage of patients with 
K1 bacteremia had liver abscesses at the site of infection 
(46.3% vs. 13.5%; OR 5.53, 95% CI 1.80–17.02, p = 
0.003).
Characteristics of patients with community-onset 
K.  pneumoniae bacteremia were also analyzed (online 
Appendix Table 2, www.cdc.gov/EID/content/17/6/1113-
appT2.htm). Patients infected with a K1 serotype were 
more likely to have liver abscesses and less likely to have 
UTIs or biliary tract infections (OR 11.5, 95% CI 3.99–
33.20; OR 0.20, 95% CI 0.04–0.92; and OR 0.25, 95% CI 
0.07–0.91, respectively).
In our patients, K1 and K2 serotypes were found at 
similar frequencies (18.2% and 16.4%, respectively), 
which differs from results of Fung et al., in which the K1 
serotype was more common (K1 30.8% and K2 5.1%) 
(12). Despite reported virulence of the K1 serotype, it was 
primarily responsible for community-onset bacteremia in 
patients with less severe underlying illness and associated 
with lower mortality rates. Moreover, the K1 serotype is 
associated with liver abscesses and lower mortality rates 
(2–7). Liver abscesses were found in 46% of patients with 
K1 bacteremia, and a K1 serotype was found in 63.3% of 
patients with liver abscesses.
Conclusions
Management of liver abscesses has improved in 
Taiwan because of increased physician awareness (13). 
Mortality rates for patients with K. pneumoniae bacteremia 
were lower in patients with UTIs or biliary tract infections 
(5,14), which were less common in patients infected 
with a K1 serotype. Thus, patient outcomes depend more 
on underlying conditions and severity of sepsis than on 
bacterial serotypes (5,9,14).
In our previous study of the interval until a positive 
blood culture for K. pneumoniae bacteremia was obtained 
(9), we found that higher Pittsburgh bacteremia scores, 
a time until a positive blood culture <7 hours, and active 
malignancy were associated with death. In this study, we 
found no difference in time until a positive blood culture 
was obtained for patients infected with different serotypes. 
This interval for patients infected with K1 serotypes was 
slightly longer than that for patients infected with K2 and 
non–K1/K2 serotypes. This ﬁ   nding may have resulted 
from a higher percentage of community-onset infections 
and liver abscesses and less severe underlying illness in 
patients infected with a K1 serotype.
Studies investigating K.  pneumoniae bacteremia 
have grouped K1 and K2 serotypes (3,7). However, such 
grouping may be problematic because evidence suggests 
that the K1 serotype is the major cause of primary liver 
abscesses (6). Another report showed that the genetic 
background of serotype K2 is diversiﬁ  ed, and only 1 of the 
2 major K2 clones was highly virulent in mice (15). These 
ﬁ   ndings are consistent with our clinical observations. 
Differences in symptoms of patients infected with K2 and 
non–K1/K2 serotypes were minimal, despite slightly more 
liver abscesses among patients infected with K2 serotypes, 
which was lower than for patients infected with K1 
serotypes. Because of different serotyping methods used 
(3,5,15), caution is required when interpreting data from 
various studies.
Despite greater virulence of the K1 serotype, it is 
predominant in patients with community-onset infections 
and in those with less severe underlying illness. Although 
the K1 serotype is the major cause of liver abscesses, it 
results in a lower mortality rate, which can be attributed to 
host factors.
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